当前位置:
X-MOL 学术
›
Radiat. Protect. Dosim.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
RADIATION DOSE DURING PELVIC RADIOGRAPHY IN RELATION TO BODY MASS INDEX.
Radiation Protection Dosimetry ( IF 1 ) Pub Date : 2020-04-28 , DOI: 10.1093/rpd/ncaa042 Nika Zalokar 1 , Anja Resnik 1 , Nejc Mekiš 1
Radiation Protection Dosimetry ( IF 1 ) Pub Date : 2020-04-28 , DOI: 10.1093/rpd/ncaa042 Nika Zalokar 1 , Anja Resnik 1 , Nejc Mekiš 1
Affiliation
The purpose of this research was to investigate the impact of body mass index (BMI) on dose area product (DAP), effective dose (E), dose to the organs and image quality (IQ) on 200 patients referred to pelvic radiography. Patients were classified into three groups according to BMI: normal (<24.99), overweight (25.0-29.99) and obese (>30). The results showed 52% and 135% higher DAP for overweight and obese patients compared to normal-weight patients (p < 0.001). A 46 and 123% rise of E for overweight and obese patients compared to normal-weight patients (p < 0.001) was discovered. Overweight patients received 37% higher dose and obese patients 107% higher dose to the organs compared to normal-weight patients. There were no statistically significant differences between IQ, except between normal weight and overweight patients. A strong correlation (r = 0.733) was found between BMI and DAP and between BMI and E (r = 0.776).
中文翻译:
与人体质量指数有关的射线照相期间的辐射剂量。
这项研究的目的是研究体重指数(BMI)对200名接受骨盆造影的患者的剂量面积乘积(DAP),有效剂量(E),器官剂量和图像质量(IQ)的影响。根据BMI将患者分为三组:正常(<24.99),超重(25.0-29.99)和肥胖(> 30)。结果显示,超重和肥胖患者的DAP比正常体重患者高52%和135%(p <0.001)。与正常体重的患者相比,超重和肥胖患者的E分别升高了46%和123%(p <0.001)。与正常体重的患者相比,超重患者的器官使用剂量增加了37%,肥胖患者的器官使用剂量增加了107%。除了正常体重和超重患者之间,智商之间没有统计学上的显着差异。
更新日期:2020-04-28
中文翻译:
与人体质量指数有关的射线照相期间的辐射剂量。
这项研究的目的是研究体重指数(BMI)对200名接受骨盆造影的患者的剂量面积乘积(DAP),有效剂量(E),器官剂量和图像质量(IQ)的影响。根据BMI将患者分为三组:正常(<24.99),超重(25.0-29.99)和肥胖(> 30)。结果显示,超重和肥胖患者的DAP比正常体重患者高52%和135%(p <0.001)。与正常体重的患者相比,超重和肥胖患者的E分别升高了46%和123%(p <0.001)。与正常体重的患者相比,超重患者的器官使用剂量增加了37%,肥胖患者的器官使用剂量增加了107%。除了正常体重和超重患者之间,智商之间没有统计学上的显着差异。